Hyaluronic acid- b -polylactic acid polymersomes facilitate CD44-mediated delivery of doxorubicin to glioblastoma in vitro
Hyaluronic acid- b -polylactic acid polymersomes encapsulate and deliver doxorubicin (DOX) to glioblastoma cells through the CD44 receptor. They degrade in an acidic tumor-mimetic environment to release DOX, causing cell death.
Authors
- Torrick Fletcher
- Jessica Larsen (ORCID: https://orcid.org/0000-0003-2756-9523)
- Apoorvi Chaudhri (ORCID: https://orcid.org/0000-0002-8785-234X)
- Molli Garifo (ORCID: https://orcid.org/0000-0003-0414-3108)
- Pranavi Thatavarthi
Institutions
- Clemson University (US)
Publication Details
- Journal
- RSC Pharmaceutics
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1039/d6pm00188b
- Citations
- 1
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 1.01
Funders
- National Science Foundation
- American Cancer Society
- U.S. Department of Education
- National Institutes of Health
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
- Division of Materials Research
- Division of Chemical, Bioengineering, Environmental, and Transport Systems